Genomics

Our renowned  team of researchers are advancing understandings of precision medicine, from the examination of metabolites to profile responses to inhaled corticosteroids to the cost-effectiveness of screening newborns for genetic risk factors. Using a multidisciplinary approach, our team is conducting high-profile epidemiological, clinical, and economic studies. Highlights include:

  • The Precision Medicine Policy and Treatment (PreEMPT) Model, a detailed mathematical model that simulates the natural history, clinical outcomes, and cost-effectiveness of integrating genomic sequencing into newborn screening
  • Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT), an epidemiological study that elucidates how age modulates genetic, genomic and metabolomic information in response to asthma medications.
  • The BabySeq Project, a multisite randomized controlled trial of integrating genome sequencing into the are of healthy newborns
  • Imagenetics METRICS, an observational study of elective genetic screening that disclosed pharmacogenomic and disease risk information as an elective clinical service to primary care patients.

Related News and Recent Publications

For more information on the Center's work please contact Ryan Walsh